CALUMET INC (CLMT) Stock Fundamental Analysis

NASDAQ:CLMT • US1314281049

28.14 USD
-1.25 (-4.25%)
At close: Feb 20, 2026
28.14 USD
0 (0%)
After Hours: 2/20/2026, 8:24:38 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

CLMT gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 206 industry peers in the Oil, Gas & Consumable Fuels industry. Both the profitability and financial health of CLMT have multiple concerns. CLMT is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • CLMT had negative earnings in the past year.
  • CLMT had a negative operating cash flow in the past year.
  • CLMT had negative earnings in 4 of the past 5 years.
  • In multiple years CLMT reported negative operating cash flow during the last 5 years.
CLMT Yearly Net Income VS EBIT VS OCF VS FCFCLMT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

1.2 Ratios

  • CLMT's Return On Assets of -1.36% is on the low side compared to the rest of the industry. CLMT is outperformed by 72.82% of its industry peers.
  • CLMT has a Return On Invested Capital (5.73%) which is comparable to the rest of the industry.
  • The Average Return On Invested Capital over the past 3 years for CLMT is significantly below the industry average of 21.97%.
Industry RankSector Rank
ROA -1.36%
ROE N/A
ROIC 5.73%
ROA(3y)-4.08%
ROA(5y)-6.46%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)7.03%
ROIC(5y)N/A
CLMT Yearly ROA, ROE, ROICCLMT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100

1.3 Margins

  • CLMT has a Operating Margin of 3.51%. This is in the lower half of the industry: CLMT underperforms 66.50% of its industry peers.
  • In the last couple of years the Operating Margin of CLMT has declined.
  • CLMT has a Gross Margin of 8.21%. This is in the lower half of the industry: CLMT underperforms 72.82% of its industry peers.
  • CLMT's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 3.51%
PM (TTM) N/A
GM 8.21%
OM growth 3YN/A
OM growth 5Y-41.55%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.67%
GM growth 5Y-15.88%
CLMT Yearly Profit, Operating, Gross MarginsCLMT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CLMT is destroying value.
  • CLMT has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, CLMT has more shares outstanding
  • Compared to 1 year ago, CLMT has a worse debt to assets ratio.
CLMT Yearly Shares OutstandingCLMT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
CLMT Yearly Total Debt VS Total AssetsCLMT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

  • Based on the Altman-Z score of 1.36, we must say that CLMT is in the distress zone and has some risk of bankruptcy.
  • CLMT has a Altman-Z score of 1.36. This is comparable to the rest of the industry: CLMT outperforms 51.94% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 1.36
ROIC/WACC0.65
WACC8.81%
CLMT Yearly LT Debt VS Equity VS FCFCLMT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B 2B

2.3 Liquidity

  • A Current Ratio of 1.13 indicates that CLMT should not have too much problems paying its short term obligations.
  • CLMT has a Current ratio (1.13) which is comparable to the rest of the industry.
  • CLMT has a Quick Ratio of 1.13. This is a bad value and indicates that CLMT is not financially healthy enough and could expect problems in meeting its short term obligations.
  • CLMT has a Quick ratio of 0.62. This is in the lower half of the industry: CLMT underperforms 69.90% of its industry peers.
Industry RankSector Rank
Current Ratio 1.13
Quick Ratio 0.62
CLMT Yearly Current Assets VS Current LiabilitesCLMT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • CLMT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 58.33%, which is quite impressive.
  • CLMT shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -22.49%.
  • The Revenue has been growing slightly by 3.94% on average over the past years.
EPS 1Y (TTM)58.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%405.93%
Revenue 1Y (TTM)-22.49%
Revenue growth 3Y9.99%
Revenue growth 5Y3.94%
Sales Q2Q%-2.04%

3.2 Future

  • The Earnings Per Share is expected to grow by 23.37% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, CLMT will show a small growth in Revenue. The Revenue will grow by 5.84% on average per year.
EPS Next Y86.86%
EPS Next 2Y32.54%
EPS Next 3Y24.43%
EPS Next 5Y23.37%
Revenue Next Year1.6%
Revenue Next 2Y-0.68%
Revenue Next 3Y1.71%
Revenue Next 5Y5.84%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CLMT Yearly Revenue VS EstimatesCLMT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B
CLMT Yearly EPS VS EstimatesCLMT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 2 -2 4 -4

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • CLMT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CLMT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CLMT Price Earnings VS Forward Price EarningsCLMT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, CLMT is valued a bit more expensive than 66.50% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 16.8
CLMT Per share dataCLMT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

  • A more expensive valuation may be justified as CLMT's earnings are expected to grow with 24.43% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y32.54%
EPS Next 3Y24.43%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for CLMT!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CALUMET INC

NASDAQ:CLMT (2/20/2026, 8:24:38 PM)

After market: 28.14 0 (0%)

28.14

-1.25 (-4.25%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)11-07
Earnings (Next)02-27
Inst Owners52.96%
Inst Owner Change-0.65%
Ins Owners2.98%
Ins Owner Change-0.16%
Market Cap2.44B
Revenue(TTM)4.05B
Net Income(TTM)-37.20M
Analysts78.33
Price Target19.13 (-32.02%)
Short Float %8.51%
Short Ratio5.3
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)369.74%
Min EPS beat(2)-407.62%
Max EPS beat(2)1147.11%
EPS beat(4)2
Avg EPS beat(4)105.83%
Min EPS beat(4)-407.62%
Max EPS beat(4)1147.11%
EPS beat(8)4
Avg EPS beat(8)44.84%
EPS beat(12)6
Avg EPS beat(12)-404.2%
EPS beat(16)6
Avg EPS beat(16)-335.84%
Revenue beat(2)2
Avg Revenue beat(2)4.63%
Min Revenue beat(2)0.47%
Max Revenue beat(2)8.78%
Revenue beat(4)4
Avg Revenue beat(4)4.89%
Min Revenue beat(4)0.47%
Max Revenue beat(4)9.31%
Revenue beat(8)8
Avg Revenue beat(8)7.08%
Revenue beat(12)11
Avg Revenue beat(12)7.22%
Revenue beat(16)15
Avg Revenue beat(16)10.04%
PT rev (1m)-14.04%
PT rev (3m)-7.69%
EPS NQ rev (1m)39.93%
EPS NQ rev (3m)0.6%
EPS NY rev (1m)-126.67%
EPS NY rev (3m)92.14%
Revenue NQ rev (1m)-1.44%
Revenue NQ rev (3m)-4.39%
Revenue NY rev (1m)-0.35%
Revenue NY rev (3m)1.19%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.6
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 16.8
EPS(TTM)-1.15
EYN/A
EPS(NY)-0.64
Fwd EYN/A
FCF(TTM)-0.87
FCFYN/A
OCF(TTM)-0.13
OCFYN/A
SpS46.66
BVpS-8.01
TBVpS-8.01
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.36%
ROE N/A
ROCE 7.26%
ROIC 5.73%
ROICexc 6.03%
ROICexgc 6.03%
OM 3.51%
PM (TTM) N/A
GM 8.21%
FCFM N/A
ROA(3y)-4.08%
ROA(5y)-6.46%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)7.03%
ROIC(5y)N/A
ROICexc(3y)7.12%
ROICexc(5y)N/A
ROICexgc(3y)8.23%
ROICexgc(5y)N/A
ROCE(3y)8.9%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-44.77%
ROICexc growth 3YN/A
ROICexc growth 5Y-43.65%
OM growth 3YN/A
OM growth 5Y-41.55%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.67%
GM growth 5Y-15.88%
F-Score4
Asset Turnover1.48
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 7.38
Cap/Depr 43.36%
Cap/Sales 1.6%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.13
Quick Ratio 0.62
Altman-Z 1.36
F-Score4
WACC8.81%
ROIC/WACC0.65
Cap/Depr(3y)260.7%
Cap/Depr(5y)180.19%
Cap/Sales(3y)6.59%
Cap/Sales(5y)4.87%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)58.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%405.93%
EPS Next Y86.86%
EPS Next 2Y32.54%
EPS Next 3Y24.43%
EPS Next 5Y23.37%
Revenue 1Y (TTM)-22.49%
Revenue growth 3Y9.99%
Revenue growth 5Y3.94%
Sales Q2Q%-2.04%
Revenue Next Year1.6%
Revenue Next 2Y-0.68%
Revenue Next 3Y1.71%
Revenue Next 5Y5.84%
EBIT growth 1Y1018.9%
EBIT growth 3YN/A
EBIT growth 5Y-39.24%
EBIT Next Year3099.02%
EBIT Next 3Y265.26%
EBIT Next 5Y148.39%
FCF growth 1Y83.48%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y80.87%
OCF growth 3YN/A
OCF growth 5YN/A

CALUMET INC / CLMT FAQ

What is the ChartMill fundamental rating of CALUMET INC (CLMT) stock?

ChartMill assigns a fundamental rating of 2 / 10 to CLMT.


What is the valuation status for CLMT stock?

ChartMill assigns a valuation rating of 1 / 10 to CALUMET INC (CLMT). This can be considered as Overvalued.


Can you provide the profitability details for CALUMET INC?

CALUMET INC (CLMT) has a profitability rating of 1 / 10.


What is the earnings growth outlook for CALUMET INC?

The Earnings per Share (EPS) of CALUMET INC (CLMT) is expected to grow by 86.86% in the next year.


Is the dividend of CALUMET INC sustainable?

The dividend rating of CALUMET INC (CLMT) is 0 / 10 and the dividend payout ratio is 0%.